BENEDETTI, PIETRO
 Distribuzione geografica
Continente #
NA - Nord America 1.965
EU - Europa 337
AS - Asia 121
Totale 2.423
Nazione #
US - Stati Uniti d'America 1.964
IT - Italia 117
UA - Ucraina 73
CN - Cina 69
FI - Finlandia 46
DE - Germania 44
IN - India 35
SE - Svezia 29
GB - Regno Unito 20
VN - Vietnam 14
NL - Olanda 3
FR - Francia 2
IE - Irlanda 2
OM - Oman 2
CA - Canada 1
DK - Danimarca 1
JP - Giappone 1
Totale 2.423
Città #
Fairfield 289
Jacksonville 269
Woodbridge 177
Houston 144
Ashburn 142
Chandler 128
Ann Arbor 123
Wilmington 107
Cambridge 106
Seattle 106
Princeton 86
Padova 37
San Diego 26
Des Moines 22
Beijing 21
Boardman 19
Roxbury 19
Nanjing 17
Dong Ket 14
Helsinki 12
Medford 10
Guangzhou 8
Jiaxing 6
Milan 6
Shenyang 6
Falls Church 5
Norwalk 5
Asiago 4
Rome 4
Catania 3
Hebei 3
New York 3
Piemonte 3
Redwood City 3
Changsha 2
Chiswick 2
Dallas 2
Dublin 2
Este 2
Indiana 2
London 2
Nanchang 2
Savigliano 2
Tappahannock 2
Vicenza 2
Chiampo 1
Copenhagen 1
Galliate 1
Haikou 1
Hounslow 1
Kharkiv 1
Muscat 1
Ningbo 1
Ottawa 1
Pavia 1
Piazzola Sul Brenta 1
Rockville 1
San Francisco 1
San Mateo 1
Tianjin 1
Tokyo 1
Treviso 1
Zhengzhou 1
Totale 1.973
Nome #
Disulfide cross-links reveal conserved features of DNA topoisomerase I architecture and a role for the n terminus in clamp closure 149
A single mutation in the 729 residue modulates human DNA topoisomerase IB DNA binding and drug resistance. 125
Production of bioethanol under high pressure of CO2: The effect of process conditions 120
null 110
Mechanisms regulating cellular responses to DNA topoisomerase I-targeted agents 109
Biologia Molecolare terza edizione 105
Thr729 in human topoisomerase I modulates anti-cancer drug resistance by altering protein domain communications as suggested by molecular dynamics simulations 104
Study of Yeast DNA Topoisomerase II and Its Truncation Derivatives by Transmission Electron Microscopy 91
Alterations in linker flexibility suppress DNA topoisomerase I mutant-induced cell lethality 85
Comparative mutational analysis of wild-type and stretched tRNALeu3 gene promoters. 81
Locking the DNA topoisomerase I protein clamp inhibits DNA rotation and induces cell lethality 78
Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain 75
Purification and characterization of Xenopus laevis topoisomerase II. 74
The Deubiquitinating Enzyme Doa4p Protects Cells from DNA Topoisomerase I Poisons 72
Holoenzyme assembly and ATP-mediated conformational dynamics of topoisomerase VI 71
Yeast as a model organism for studying the actions of DNA topoisomerase-targeted drugs. 68
Effect on DNA relaxation of the single Thr718Ala mutation in human topoisomerase I: a functional and molecular dynamics study 67
Drug-induced stabilization of covalent DNA topoisomerase I-DNA intermediates. DNA cleavage assays 64
The Use of Yeast and Yeast Strains Expressing Human DNA Topoisomerases in the Study of Anticancer Drugs. Drug Resistance as a Biochemical Target in Cancer Chemiotherapy (T.Tsuruo, M. Ogawa and S.K. Carter, eds) Academic Press, San Diego CA 60
Visualization of DNA Topoisomerases by Electron Microscopy. 60
Separation of RNA transcription and processing activities from Xenopus laevis. . 55
Yeast Saccharomyces cerevisiae as a model system to study the cytotoxic activity of the antitumor drug camptothecin. 53
Molecular Dissection of a Protein SopB Essential for E.coli F Plasmid Partition. 52
Domain Interactions Affecting Human DNA Topoisomerase I Catalysis and Camptothecin Sensitivity. Molecular Phamacology 56:1105-1115 (1999). 52
Artemisinin Derivatives with Antimelanoma Activity Show Inhibitory Effect against Human DNA Topoisomerase 1 50
Protein concerted motions in the DNA-Human Topoisomerase I complex 49
Spontaneous Formation of Topoisomerase II Multimers in vitro: Effects of Metals, b-Gycerophosphate and Phosphorylation of its C-Terminal Domain 47
tecniche e metodi per la biologia molecolare 43
Expression of Human DNA Topoisomerase I in Yeast Cells Lacking Yeast Topoisomerase I: Restoration of Sensitivity of the Cells to the Antitumor Drug Campothecin. 41
Template Supercoiling by a Yeast GAL4 Protein-Phage T7 RNA Polymerase Chimera. Science (1990) 249: 1261-1265 41
Single mutation in the linker domain confers protein flexibility and camptothecin resistance to human topoisomerase I J. Biol. Chem., Aug 2003 38
Analysis of Camptothecin resistance in yeast: relevance to cancer therapy. 29
In vitro catenation and decatenation of DNA and a novel ATP-dependent topoisomerase. 24
Increased camptothecin toxicity in mammalian cells expressing Saccharomyces cerevisiae DNA topoisomerase I. 23
Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine. 21
RNA: una molecola per tutte le stagioni 17
Il racconto delle origini. Dal Big bang alla vita. 15
Solution structures of 2x6-meric and 4x6-meric hemocyanins of crustaceans Carcinus aestuarii, Squilla mantis and Upogebia pusilla. 14
Viruses responsible for emerging deseases in south- east asia 8
Totale 2.440
Categoria #
all - tutte 6.899
article - articoli 5.720
book - libri 392
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 787
Totale 13.798


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019184 0 0 0 0 0 0 0 0 0 37 80 67
2019/2020593 75 13 17 44 59 53 42 67 51 51 85 36
2020/2021491 9 36 12 58 86 38 10 42 74 28 63 35
2021/2022411 11 55 41 34 24 15 32 43 25 6 51 74
2022/2023331 79 36 15 19 52 45 3 24 32 1 14 11
2023/2024103 17 20 31 12 8 4 0 4 2 5 0 0
Totale 2.440